Michael Rider - ResMed Chief Secretary
| RME Stock | EUR 215.40 1.40 0.65% |
Executive
Michael Rider is Chief Secretary of ResMed Inc
| Age | 68 |
| Address | 9001 Spectrum Center Boulevard, San Diego, CA, United States, 92123 |
| Phone | 858-836-5000 |
| Web | https://www.resmed.com |
Michael Rider Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Rider against ResMed stock is an integral part of due diligence when investing in ResMed. Michael Rider insider activity provides valuable insight into whether ResMed is net buyers or sellers over its current business cycle. Note, ResMed insiders must abide by specific rules, including filing SEC forms every time they buy or sell ResMed'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Rider over a year ago Disposition of tradable shares by Michael Rider of ResMed at 248.91 subject to Rule 16b-3 | ||
Michael Rider over a year ago Disposition of 173 shares by Michael Rider of ResMed subject to Rule 16b-3 | ||
Michael Rider over a year ago Disposition of 200 shares by Michael Rider of ResMed at 173.25 subject to Rule 16b-3 |
ResMed Management Efficiency
The company has return on total asset (ROA) of 0.1475 % which means that it generated a profit of $0.1475 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2568 %, meaning that it generated $0.2568 on every $100 dollars invested by stockholders. ResMed's management efficiency ratios could be used to measure how well ResMed manages its routine affairs as well as how well it operates its assets and liabilities. At this time, ResMed's Other Current Assets are most likely to increase significantly in the upcoming years. The ResMed's current Total Current Assets is estimated to increase to about 4.2 B, while Total Assets are projected to decrease to roughly 5 B.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Victoria Gehris | Quaker Chemical | N/A | |
| Miguel Hernandez | Quaker Chemical | 48 | |
| Kristin Rokosky | Quaker Chemical | 55 | |
| Jeffrey Fleck | Quaker Chemical | 56 | |
| Koichi Ogino | Sumitomo Chemical | N/A | |
| Jeewat Bijlani | Quaker Chemical | 48 | |
| Anton BTech | Harmony Gold Mining | 61 | |
| Xuelin CPA | Zijin Mining Group | 49 | |
| Brad Lich | Eastman Chemical | 58 | |
| BAcc BCom | Perseus Mining Limited | 52 | |
| Jacob Ricciardone | Perseus Mining Limited | N/A | |
| Travis Smith | Eastman Chemical | 51 | |
| Christopher Woodall | Perseus Mining Limited | N/A | |
| Megumi Sakuramoto | Sumitomo Chemical | N/A | |
| Juan Ferreira | Sumitomo Chemical | N/A | |
| Julie McAlindon | Eastman Chemical | 58 | |
| Seiji Takeuchi | Sumitomo Chemical | 64 | |
| Brett Hartmann | Perseus Mining Limited | N/A | |
| Hendrik BCom | Harmony Gold Mining | 61 | |
| Adrian Holt | Eastman Chemical | 57 | |
| Hirokazu Murata | Sumitomo Chemical | N/A | |
Management Performance
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.15 |
ResMed Inc Leadership Team
Elected by the shareholders, the ResMed's board of directors comprises two types of representatives: ResMed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ResMed. The board's role is to monitor ResMed's management team and ensure that shareholders' interests are well served. ResMed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ResMed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| AM BE, Chair Founder | ||
| Justin Leong, Chief Officer | ||
| Michael Rider, Chief Secretary | ||
| Robert Douglas, Pres COO | ||
| Vered Keisar, Chief Officer | ||
| Kaushik Ghoshal, Pres Bus | ||
| YvonneKatrin Pucknat, Chief Officer | ||
| Sallilyn Schwartz, Chief Officer | ||
| Amy Wakeham, VP Communications | ||
| Brett Sandercock, Chief Officer | ||
| BE MBA, CEO Director | ||
| AM AM, Founder Chairman | ||
| David Pendarvis, Global Officer | ||
| Jim Ellis, Chief Officer | ||
| Alastair Robertson, Chief Officer | ||
| Constance Bienfait, Director Relations | ||
| Urvashi Tyagi, Chief Officer |
ResMed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ResMed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.26 | ||||
| Return On Asset | 0.15 | ||||
| Profit Margin | 0.28 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 31.21 B | ||||
| Shares Outstanding | 145.68 M | ||||
| Shares Owned By Insiders | 0.53 % | ||||
| Shares Owned By Institutions | 68.10 % | ||||
| Price To Earning | 41.49 X | ||||
| Price To Book | 5.83 X |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..